These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 17058288

  • 1. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
    Kruper LL, Spitz FR, Czerniecki BJ, Fraker DL, Blackwood-Chirchir A, Ming ME, Elder DE, Elenitsas R, Guerry D, Gimotty PA.
    Cancer; 2006 Nov 15; 107(10):2436-45. PubMed ID: 17058288
    [Abstract] [Full Text] [Related]

  • 2. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.
    Eur J Cancer; 2009 Sep 15; 45(14):2537-45. PubMed ID: 19553103
    [Abstract] [Full Text] [Related]

  • 3. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.
    J Clin Oncol; 2007 Mar 01; 25(7):869-75. PubMed ID: 17327608
    [Abstract] [Full Text] [Related]

  • 4. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.
    Arch Dermatol; 2008 Apr 01; 144(4):462-7. PubMed ID: 18427039
    [Abstract] [Full Text] [Related]

  • 5. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S.
    Cancer; 2001 Jun 15; 91(12):2401-8. PubMed ID: 11413531
    [Abstract] [Full Text] [Related]

  • 6. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR.
    Cancer; 2010 Mar 15; 116(6):1535-44. PubMed ID: 20108306
    [Abstract] [Full Text] [Related]

  • 7. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
    Paek SC, Griffith KA, Johnson TM, Sondak VK, Wong SL, Chang AE, Cimmino VM, Lowe L, Bradford CR, Rees RS, Sabel MS.
    Cancer; 2007 Jan 01; 109(1):100-8. PubMed ID: 17146784
    [Abstract] [Full Text] [Related]

  • 8. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
    Vaquerano J, Kraybill WG, Driscoll DL, Cheney R, Kane JM.
    Ann Surg Oncol; 2006 Feb 01; 13(2):198-204. PubMed ID: 16418885
    [Abstract] [Full Text] [Related]

  • 9. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.
    Kesmodel SB, Karakousis GC, Botbyl JD, Canter RJ, Lewis RT, Wahl PM, Terhune KP, Alavi A, Elder DE, Ming ME, Guerry D, Gimotty PA, Fraker DL, Czerniecki BJ, Spitz FR.
    Ann Surg Oncol; 2005 Jun 01; 12(6):449-58. PubMed ID: 15864482
    [Abstract] [Full Text] [Related]

  • 10. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
    Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.
    Eur J Surg Oncol; 2008 Jan 01; 34(1):82-8. PubMed ID: 17360144
    [Abstract] [Full Text] [Related]

  • 11. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM.
    Arch Dermatol; 2005 Aug 01; 141(8):1016-22. PubMed ID: 16103331
    [Abstract] [Full Text] [Related]

  • 12. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma.
    Vuylsteke RJ, Borgstein PJ, van Leeuwen PA, Gietema HA, Molenkamp BG, Statius Muller MG, van Diest PJ, van der Sijp JR, Meijer S.
    Ann Surg Oncol; 2005 Jun 01; 12(6):440-8. PubMed ID: 15864481
    [Abstract] [Full Text] [Related]

  • 13. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L.
    Br J Dermatol; 2007 Jul 01; 157(1):58-67. PubMed ID: 17501957
    [Abstract] [Full Text] [Related]

  • 14. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.
    J Am Acad Dermatol; 2001 May 01; 44(5):762-6. PubMed ID: 11312421
    [Abstract] [Full Text] [Related]

  • 15. Sentinel lymph node status in melanoma: a valuable prognostic factor?
    Topar G, Eisendle K, Zelger B, Fritsch P.
    Br J Dermatol; 2006 Jun 01; 154(6):1080-7. PubMed ID: 16704637
    [Abstract] [Full Text] [Related]

  • 16. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF.
    J Clin Oncol; 2012 Jul 20; 30(21):2678-83. PubMed ID: 22711850
    [Abstract] [Full Text] [Related]

  • 17. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.
    Ann Surg Oncol; 2006 Dec 20; 13(12):1655-63. PubMed ID: 17016755
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
    Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, Flaig M, Ruzicka T, Berking C, Schmid-Wendtner MH.
    Melanoma Res; 2010 Aug 20; 20(4):330-7. PubMed ID: 20526218
    [Abstract] [Full Text] [Related]

  • 19. Predictors of regional nodal disease in patients with thin melanomas.
    Karakousis GC, Gimotty PA, Botbyl JD, Kesmodel SB, Elder DE, Elenitsas R, Ming ME, Guerry D, Fraker DL, Czerniecki BJ, Spitz FR.
    Ann Surg Oncol; 2006 Apr 20; 13(4):533-41. PubMed ID: 16523360
    [Abstract] [Full Text] [Related]

  • 20. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
    Sabel MS, Griffith K, Sondak VK, Lowe L, Schwartz JL, Cimmino VM, Chang AE, Rees RS, Bradford CR, Johnson TM.
    J Am Coll Surg; 2005 Jul 20; 201(1):37-47. PubMed ID: 15978442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.